Synthetic Metabolic and Genetic Networks for Medical Diagnosics (NCT04518072) | Clinical Trial Compass
TerminatedNot Applicable
Synthetic Metabolic and Genetic Networks for Medical Diagnosics
Stopped: delay in erolement, decision of the sponsor
France134 participantsStarted 2021-01-06
Plain-language summary
This is a category 3 human study, prospective, comparative, in parallel groups. A comparative qualitative and quantitative analysis of several markers in 250 samples is proposed.
Who can participate
Age range18 Years
SexMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Men aged over 18
* Informed, written consent of the patient for the biological collection
* Subject affiliated to a French social security scheme or beneficiary of such a scheme
Patients specific inclusion criteria :
\- Admitted to care prostate disease or suspicion of prostate cancer and with a positive or negative PSA blood result
Controls specific inclusion criteria :
\- Man free from all prostate or bladder pathologies
Exclusion Criteria:
* Patient under legal protection
* Persons deprived of their liberty, protected adults or vulnerable persons
* Participants may withdraw their consent at any time and for any reason whatsoever without incurring any negative consequences without change in their usual care
Controls specific non-inclusion criteria :
* Patient with current prostatic or urinary infection
* History of treatment for prostate cancer other than surveillance management
What they're measuring
1
Ability to detect and quantify biomarkers such as PSA in samples using biosensors platform